Additional Agents The mechanism of action of some drugs remain unknown, but the excellent efficacy of these drugs in the radiosensitization of osteosarcoma deserves our attention
In type 2 diabetes management, for example, NICE guideline NG28 supports the use of multiple agents with complementary mechanisms when monotherapy is insufficient
The time the body requires to break down the drug completely can increase with higher doses, resulting in longer drug retention
Contact your healthcare provider immediately if you take tirzepatide or another GIP/GLP-1 RA and experience side effects, including: Changes in vision Diarrhea, nausea and vomiting Difficulty breathing Difficulty swallowing Dizziness or lightheadedness Jaundice (yellowing of the skin or eyes) Lump or swelling in the neck Rapid heartbeat Rash or swelling of the face, lips, tongue or throat Severe stomach pain Tirzepatide severe side effects and complications Some patients who use tirzepatide may experience severe side effects or adverse health reactions
Oral tranexamic acid was originally FDA approved to treat bleeding disorders
DMEM (1 ml/well) containing 10% FBS and the specified reagents was added on top of each collagen gel